Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
MAIA Biotechnology, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Theagene Jean-Manasse (Director) has filed a Form 4 on MAIA Biotechnology, Inc.|
Txns:
| Granted 8,378 options
@ $2.2, valued at
$18.4k
|
|
| 10/03/2023 |
4
| Luput Cristian (Director) has filed a Form 4 on MAIA Biotechnology, Inc.|
Txns:
| Granted 8,378 options
@ $2.2, valued at
$18.4k
|
|
| 10/03/2023 |
4
| Louie Ngar Yee (Director) has filed a Form 4 on MAIA Biotechnology, Inc.|
Txns:
| Granted 12,567 options
@ $2.2, valued at
$27.6k
|
|
| 10/03/2023 |
4
| Guerrero Ramiro (Director) has filed a Form 4 on MAIA Biotechnology, Inc.|
Txns:
| Granted 8,378 options
@ $2.2, valued at
$18.4k
|
|
| 10/03/2023 |
4
| CHAOUKI STEVEN M (Director) has filed a Form 4 on MAIA Biotechnology, Inc.|
Txns:
| Granted 8,378 options
@ $2.2, valued at
$18.4k
|
|
| 10/03/2023 |
4
| Smith Stan (Director) has filed a Form 4 on MAIA Biotechnology, Inc.|
Txns:
| Granted 10,472 options
@ $2.2, valued at
$23k
|
|
| 09/28/2023 |
8-K
| Quarterly results |
| 08/24/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 07/18/2023 |
RW
| Form RW - Registration Withdrawal Request: |
| 07/11/2023 |
FWP
| Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses: |
| 07/11/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 07/10/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 07/05/2023 |
4
| CHAOUKI STEVEN M (Director) has filed a Form 4 on MAIA Biotechnology, Inc.|
Txns:
| Granted 8,910 options
@ $2.2, valued at
$19.6k
|
|
| 07/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 06/09/2023 |
FWP
| Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses: |
| 06/08/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 06/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2023 |
4
| Obrocea Mihail (Chief Medical Officer) has filed a Form 4 on MAIA Biotechnology, Inc.|
Txns:
| Granted 87,495 options
@ $2.5, valued at
$218.7k
|
|
| 06/05/2023 |
4
| MCGUIRE JOSEPH F (CFO) has filed a Form 4 on MAIA Biotechnology, Inc.|
Txns:
| Granted 69,075 options
@ $2.5, valued at
$172.7k
|
|
| 06/05/2023 |
4
| Gryaznov Sergei (Chief Scientific Officer) has filed a Form 4 on MAIA Biotechnology, Inc.|
Txns:
| Granted 75,982 options
@ $2.5, valued at
$190k
|
|
| 05/17/2023 |
4
| Luput Cristian (Director) has filed a Form 4 on MAIA Biotechnology, Inc.|
Txns:
| Bought 3,000 shares
@ $2.63, valued at
$7.9k
|
|
| 05/08/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/08/2023 |
8-K
| Quarterly results |
| 05/01/2023 |
4
| Vitoc Vlad (CEO) has filed a Form 4 on MAIA Biotechnology, Inc.|
Txns:
| Bought 4,000 shares
@ $2.5, valued at
$10k
|
|
| 04/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2023 |
4
| Louie Ngar Yee (Director) has filed a Form 4 on MAIA Biotechnology, Inc.|
Txns:
| Bought 48,000 shares
@ $2.25, valued at
$108k
|
|
|
|
|